The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases
Open accessAbstract
Advanced glycation end products (AGEs) are generated by nonenzymatic modifications of macromolecules (proteins, lipids, and nucleic acids) by saccharides (glucose, fructose, and pentose) via Maillard reaction. The formed AGE molecules can be catabolized and cleared by glyoxalase I and II in renal proximal tubular cells. AGE-related diseases include physiological aging, neurodegenerative/neuroinflammatory diseases, diabetes mellitus (DM) and its complications, autoimmune/rheumatic inflammatory diseases, bone-degenerative diseases, and chronic renal diseases. AGEs, by binding to receptors for AGE (RAGEs), alter innate and adaptive immune responses to induce inflammation and immunosuppression via the generation of proinflammatory cytokines, reactive oxygen species (ROS), and reactive nitrogen intermediates (RNI). These pathological molecules cause vascular endothelial/smooth muscular/connective tissue-cell and renal mesangial/endothelial/podocytic-cell damage in AGE-related diseases. In the present review, we first focus on the cellular and molecular bases of AGE–RAGE axis signaling pathways in AGE-related diseases. Then, we discuss in detail the modes of action of newly discovered novel biomolecules and phytochemical compounds, such as Maillard reaction and AGE–RAGE signaling inhibitors. These molecules are expected to become the new therapeutic strategies for patients with AGE-related diseases in addition to the traditional hypoglycemic and anti-hypertensive agents. We particularly emphasize the importance of “metabolic memory”, the “French paradox”, and the pharmacokinetics and therapeutic dosing of the effective natural compounds associated with pharmacogenetics in the treatment of AGE-related diseases. Lastly, we propose prospective investigations for solving the enigmas in AGE-mediated pathological effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Flavonoids: a review of probable mechanisms of action and potential applications
Nijveldt, R. J., van Nood, E., van Hoorn, D. E., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.418 · Cited by 3,075
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,224
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150 · cited 3×
“Briefly, the glycation of proteins is induced by MR in three steps: (1) the slow formation of Schiff bases, (2) the early formed unstable AGE precursors that may underlie Amadori rearrangement, and (3) the formation of late irreversible AGE products [31,32].”
BackgroundEl-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Frank, R. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmra021678 · Cited by 891
Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., & Aldini, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.815348 · Cited by 823
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., & Vlassara, H. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.427 · Cited by 570
Wautier, J. L., Zoukourian, C., Chappey, O., Wautier, M. P., Guillausseau, P. J., Cao, R., Hori, O., Stern, D., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118397 · Cited by 552
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
Methylglyoxal, the dark side of glycolysis
Allaman, I., Bélanger, M., & Magistretti, P. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00023 · Cited by 547
Maillard reaction products in tissue proteins: New products and new perspectives
Thorpe, S. R., & Baynes, J. W. (2003) · Amino Acids · doi:10.1007/s00726-003-0017-9 · Cited by 543
Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Moldogazieva, N. T., Mokhosoev, I. M., Mel’nikova, T. I., Porozov, Y. B., & Terentiev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3085756 · Cited by 493
Does accumulation of advanced glycation end products contribute to the aging phenotype?
Semba, R. D., Nicklett, E. J., & Ferrucci, L. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq074 · Cited by 490
Perrone, A., Giovino, A., Benny, J., & Martinelli, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3818196 · Cited by 459
Resveratrol and Cardiovascular Diseases
Bonnefont-Rousselot, D. (2016) · Nutrients · doi:10.3390/nu8050250 · Cited by 442
Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., & Horiuchi, S. (1996) · Biochemistry · doi:10.1021/bi9530550 · Cited by 434
Dietary Advanced Glycation End Products and Aging
Luevano-Contreras, C., & Chapman-Novakofski, K. (2010) · Nutrients · doi:10.3390/nu2121247 · Cited by 396
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357
The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions
Sanajou, D., Ghorbani Haghjo, A., Argani, H., & Aslani, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.001 · Cited by 313
Xue, M., Rabbani, N., Momiji, H., Imbasi, P., Anwar, M. M., Kitteringham, N., Park, B. K., Souma, T., Moriguchi, T., Yamamoto, M., et al. (2012) · Biochemical Journal · doi:10.1042/bj20111648 · Cited by 302
Itoh, Y., Esaki, T., Shimoji, K., Cook, M., Law, M. J., Kaufman, E., & Sokoloff, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831078100 · Cited by 297
Advanced glycation endproducts in ageing and Alzheimer's disease
Münch, G., Thome, J., Foley, P., Schinzel, R., & Riederer, P. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00016-1 · Cited by 275
Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases
Reddy, V. P., & Beyaz, A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.016 · Cited by 266
Advanced glycation End-products (AGEs): an emerging concern for processed food industries
Sharma, C., Kaur, A., Thind, S. S., Singh, B., & Raina, S. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1851-y · Cited by 253
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70146-5 · Cited by 252
Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M., & Horiuchi, S. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0408h.x · Cited by 248
Aragno, M., & Mastrocola, R. (2017) · Nutrients · doi:10.3390/nu9040385 · Cited by 239
Negrean, M., Stirban, A., Stratmann, B., Gawlowski, T., Horstmann, T., Götting, C., Kleesiek, K., Mueller-Roesel, M., Koschinsky, T., Uribarri, J., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1236 · Cited by 235
Miyata, T., Ueda, Y., Shinzato, T., Iida, Y., Tanaka, S., Kurokawa, K., van Ypersele de Strihou, C., & Maeda, K. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v781198 · Cited by 232
Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health
Gill, V., Kumar, V., Singh, K., Kumar, A., & Kim, J.-J. (2019) · Biomolecules · doi:10.3390/biom9120888 · Cited by 230
Brouwers, O., Niessen, P. M., Ferreira, I., Miyata, T., Scheffer, P. G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C. D., & Schalkwijk, C. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144097 · Cited by 229
Renal catabolism of advanced glycation end products: the fate of pentosidine
Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., de Strihou, C. V. Y., & Kurokawa, K. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00756.x · Cited by 227
RAGE in tissue homeostasis, repair and regeneration
Sorci, G., Riuzzi, F., Giambanco, I., & Donato, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.021 · Cited by 227
Gugliucci, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013912 · Cited by 225
Moderate Red Wine Consumption and Cardiovascular Disease Risk: Beyond the “French Paradox”
Lippi, G., Franchini, M., Favaloro, E., & Targher, G. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1248725 · Cited by 221
Mechanistic targeting of advanced glycation end-products in age-related diseases
Rowan, S., Bejarano, E., & Taylor, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.036 · Cited by 215
Molecular mechanisms of α-synuclein neurodegeneration
Waxman, E. A., & Giasson, B. I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.013 · Cited by 213
Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
Cepas, V., Collino, M., Mayo, J. C., & Sainz, R. M. (2020) · Antioxidants · doi:10.3390/antiox9020142 · Cited by 202
α‐Synuclein produces a long‐lasting increase in neurotransmitter release
Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R. D., & Arancio, O. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600451 · Cited by 198
Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
Li, J., Qu, X., Ricardo, S. D., Bertram, J. F., & Nikolic-Paterson, D. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090923 · Cited by 197
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T., Silnikov, V., & Moinuddin (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 192
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Galasko, D., Bell, J., Mancuso, J. Y., Kupiec, J. W., Sabbagh, M. N., van Dyck, C., Thomas, R. G., Aisen, P. S., & Study, F. T. A. D. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000364 · Cited by 187
Clarke, R., Dordevic, A., Tan, S., Ryan, L., & Coughlan, M. (2016) · Nutrients · doi:10.3390/nu8030125 · Cited by 186
Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease
Ruiz, H. H., Ramasamy, R., & Schmidt, A. M. (2020) · Endocrinology · doi:10.1210/endocr/bqz006 · Cited by 184
Protein Glycation: Creation of Catalytic Sites for Free Radical Generation
Yim, M. B., Yim, H., Lee, C., Kang, S., & Chock, P. B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05634.x · Cited by 177
Scavenger receptors for oxidized and glycated proteins
Horiuchi, S., Sakamoto, Y., & Sakai, M. (2003) · Amino Acids · doi:10.1007/s00726-003-0029-5 · Cited by 175
Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes
Yamagishi, S.-I., Nakamura, N., Suematsu, M., Kaseda, K., & Matsui, T. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00067 · Cited by 173
The Renin Angiotensin Aldosterone System in Obesity and Hypertension
Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168
The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
Senatus, L. M., & Schmidt, A. M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00187 · Cited by 167
Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835aea13 · Cited by 166
Advanced Glycation Endproducts in Diabetes and Diabetic Complications
Vlassara, H., & Striker, G. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.005 · Cited by 166
Essential Structural Requirements and Additive Effects for Flavonoids to Scavenge Methylglyoxal
Shao, X., Chen, H., Zhu, Y., Sedighi, R., Ho, C.-T., & Sang, S. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500204s · Cited by 162
An update on advanced glycation endproducts and atherosclerosis
Turco, S. D., & Basta, G. (2012) · BioFactors · doi:10.1002/biof.1018 · Cited by 159
Nicholl, I. D., Stitt, A. W., Moore, J. E., Ritchie, A. J., ARCHER, D. B., & Bucala, R. (1998) · Molecular Medicine · doi:10.1007/bf03401759 · Cited by 152
Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway
Chen, Y., Kong, L., Tang, Z., Zhang, Y., Liu, Y., Wang, T., & Liu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.030 · Cited by 150
Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
Armando Rojas, R., & Morales, M. A. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.011 · Cited by 146
Kim, C., Park, S., & Kim, J. (2017) · Physical Activity and Nutrition · doi:10.20463/jenb.2017.0027 · Cited by 141
Miyata, T., Ueda, Y., Yoshida, A., Sugiyama, S., Iida, Y., Jadoul, M. Y., Maeda, K., Kurokawa, K., & de Strihou, C. V. Y. (1997) · Kidney International · doi:10.1038/ki.1997.124 · Cited by 131
Younus, H., & Anwar, S. (2016) · International Journal of Health Sciences · doi:10.12816/0048818 · Cited by 131
Yamagishi, S., Fukami, K., & Matsui, T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0176-5 · Cited by 130
Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications
Guan, B., & Zhang, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s237544 · Cited by 125
Li, S., Du, ., Dolence, E. K., Fang, C. X., Mayer, G. E., Ceylan‐Isik, A. F., LaCour, K. H., Yang, X., Wilbert, C. J., Sreejayan, N., et al. (2005) · Aging Cell · doi:10.1111/j.1474-9728.2005.00146.x · Cited by 124
Chen, Y.-S., Yan, W., Geczy, C. L., Brown, M. A., & Thomas, R. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2645 · Cited by 124
Reynaert, N. L., Gopal, P., Rutten, E. P. A., Wouters, E. F. �., & Schalkwijk, C. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.016 · Cited by 122
Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
Garrido, D., Rubin, T., Poidevin, M., Maroni, B., Rouzic, A. L., Parvy, J.-P., & Montagne, J. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004995 · Cited by 120
Cai, W., He, C., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00350.2007 · Cited by 118
Nonaka, K., Kajiura, Y., Bando, M., Sakamoto, E., Inagaki, Y., Lew, J. H., Naruishi, K., Ikuta, T., Yoshida, K., Kobayashi, T., et al. (2017) · Journal of Periodontal Research · doi:10.1111/jre.12518 · Cited by 118
George, S., & Sivakami, S. (2004) · Biogerontology · doi:10.1007/s10522-004-3189-0 · Cited by 116
Serum advanced glycation end products (AGEs) are associated with insulin resistance
Tan, K. C. B., Shiu, S. W. M., Wong, Y., & Tam, X. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1188 · Cited by 111
Yuan, Y., Sun, H. Q., & Sun, Z. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0522-6 · Cited by 106
Chen, J., Song, M., Yu, S., Gao, P., Yu, Y., Wang, H., & Huang, L. J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0250-y · Cited by 105
Ottum, M. S., & Mistry, A. M. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-3 · Cited by 101
Kintscher, U., Bramlage, P., Paar, W. D., Thoenes, M., & Unger, T. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-12 · Cited by 99
Hou, B., Qiang, G., Zhao, Y., Yang, X., Chen, X., Yan, Y., Wang, X., Liu, C., Zhang, L., & Du, G. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486154 · Cited by 98
Glyoxal Formation and Its Role in Endogenous Oxalate Synthesis
Lange, J. N., Wood, K. D., Knight, J. L., Assimos, D. G., & Holmes, R. P. (2012) · Advances in Urology · doi:10.1155/2012/819202 · Cited by 97
Miyata, T., de Strihou, C. V. Y., Imasawa, T., Yoshino, A., Ueda, Y., Ogura, H., Kominami, K., Onogi, H., Inagi, R., Nangaku, M., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00051.x · Cited by 97
The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective
Rao, T., Tan, Z., Peng, J., Guo, Y., Chen, Y., Zhou, H., & Ouyang, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104283 · Cited by 97
Houjeghani, S., Kheirouri, S., Faraji, E., & Jafarabadi, M. A. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.11.003 · Cited by 93
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
Kurz, A., Rabbani, N., Walter, M. J., von Bonin, M., Thornalley, P. J., Auburger, G. W. J., & Gispert, S. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0483-7 · Cited by 90
Dai, J., Chen, H., & Chai, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.915806 · Cited by 88
Bansal, S., Siddarth, M., Chawla, D., Banerjee, B. D., Madhu, S. V., & Tripathi, A. K. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1114-9 · Cited by 86
Abbas, G., Al-Harrasi, A. S., Hussain, H., Hussain, J., Rashid, R., & Choudhary, M. I. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1028080 · Cited by 83
Qiu, Y.-Y., Tang, L., & Wei, W. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.009 · Cited by 82
Dhar, I., Caspar‐Bell, G., & Prasad, K. (2014) · International Journal of Angiology · doi:10.1055/s-0034-1396413 · Cited by 81
Advanced Glycation End Product Homeostasis: Exogenous Oxidants and Innate Defenses
Vlassara, H., Uribarri, J., Cai, W., & Striker, G. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.055 · Cited by 77
Resveratrol, Potential Therapeutic Interest in Joint Disorders: A Critical Narrative Review
Nguyen, C., Savouret, J., Widerak, M., Corvol, M. T., & Rannou, F. (2017) · Nutrients · doi:10.3390/nu9010045 · Cited by 75
Yamagishi, S., & Matsui, T. (2015) · Nutrition · doi:10.1016/j.nut.2015.08.001 · Cited by 74
Kim, K. M., Kim, Y. S., Jung, D. H., Lee, J. H., & Kim, J. S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.10.013 · Cited by 74
Prasad, K., & Tiwari, S. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161006143032 · Cited by 73
Matsui, T., Nakamura, N., Ojima, A., Nishino, Y., & Yamagishi, S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.04.008 · Cited by 72
Kang, M., Park, S., Choi, Y. J., Shin, D., & Kang, Y. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1301-3 · Cited by 69
Metabolic Memory for Vascular Disease in Diabetes
Aschner, P. J., & Ruiz, Á. J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0012 · Cited by 66
Sanchís, P., Rivera, R., Berga, F., Fortuny, R., Adrover, M., Costa‐Bauzá, A., Grases, F., & Masmiquel, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-27853-9 · Cited by 65
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
de Leeuw, K., Graaff, R., de Vries, R., Dullaart, R. P. F., Smit, A. J., Kallenberg, C. G. M., & Bijl, M. (2007) · Rheumatology · doi:10.1093/rheumatology/kem215 · Cited by 64
Yamagishi, S. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0618 · Cited by 64
A previously undescribed chemical link between smoking and metabolic disease
Dickerson, T. J., & Janda, K. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222561699 · Cited by 63
Dietary Advanced Glycation Endproducts Induce an Inflammatory Response in Human Macrophages in Vitro
van der Lugt, T., Weseler, A. R., Gebbink, W. A., Vrolijk, M. F., Opperhuizen, A., & Bast, A. (2018) · Nutrients · doi:10.3390/nu10121868 · Cited by 58
Brix, J., Höllerl, F., Kopp, H., Schernthaner, G.-H., & Schernthaner, G.-H. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.107 · Cited by 56
Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
Parveen, A., Kim, J. H., Oh, B. G., Subedi, L., Khan, Z., & Kim, S. Y. (2018) · Molecules · doi:10.3390/molecules23071519 · Cited by 53
López-Moreno, J., Quintana‐Navarro, G. M., Delgado‐Lista, J., García‐Ríos, A., Alcala-Diaz, J. F., Gómez-Delgado, F., Camargo, A., Pérez‐Martínez, P., Tinahones, F. J., Striker, G. E., et al. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw214 · Cited by 52
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
Wetzels, S., Vanmierlo, T., Scheijen, J. L. J. M., van Horssen, J., Amor, S., Somers, V., Schalkwijk, C. G., Hendriks, J. J. A., & Wouters, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00855 · Cited by 51
López-Moreno, J., Quintana‐Navarro, G. M., Delgado‐Lista, J., García‐Ríos, A., Delgado‐Casado, N., Camargo, A., Pérez‐Martínez, P., Striker, G. E., Tinahones, F. J., Pérez‐Jiménez, F., et al. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14062 · Cited by 49
Do, M. H., Hur, J., Choi, J., Kim, M. K., Kim, M. J., Kim, Y., & Ha, S. K. (2018) · Nutrients · doi:10.3390/nu10030265 · Cited by 49
Advanced glycation end-products suppress neuropilin-1 expression in podocytes
Bondeva, T., Rüster, C., Franke, S., Hammerschmid, E., Klagsbrun, M., Cohen, C. D., & Wolf, G. (2008) · Kidney International · doi:10.1038/ki.2008.603 · Cited by 48
Pinkas, A., & Aschner, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00034 · Cited by 48
Papagrigoraki, A., Giglio, M., Cosma, C., Maurelli, M., Girolomoni, G., & Lapolla, A. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2661 · Cited by 46
Kim, J., Kim, C., Moon, M. K., & Kim, J. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.12.010 · Cited by 44
Davis, K. E., Prasad, C., Vijayagopal, P., Juma, S., ADAMS-HUET, B. A., & Imrhan, V. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003487 · Cited by 41
Babu, K. A., Sen, P., & Angayarkanni, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216899 · Cited by 41
Perkins, R. K., Miranda, E. R., Karstoft, K., Beisswenger, P. J., Solomon, T. P. J., & Haus, J. M. (2019) · Nutrients · doi:10.3390/nu11030532 · Cited by 40
Menini, S., Iacobini, C., Fantauzzi, C. B., & Pugliese, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190711102718 · Cited by 40
Koga, K., Yamagishi, S., Okamoto, T., Inagaki, Y., Amano, S., Takeuchi, M., & Makita, Z. (2002) · PubMed · Cited by 39
Resveratrol: un polifenol neuroprotector de la dieta mediterránea
González, V. L.-M., Soto‐Montenegro, M. L., Vera, G., Herradón, E., Desco, M., & Abalo, R. (2012) · Revista de Neurología · doi:10.33588/rn.5406.2011611 · Cited by 38
Sourris, K. C., Harcourt, B. E., & Forbes, J. M. (2009) · American Journal of Nephrology · doi:10.1159/000226586 · Cited by 38
Revisiting amino acids and peptides as anti-glycation agents
Chilukuri, H., Kulkarni, M. J., & Fernandes, M. (2018) · MedChemComm · doi:10.1039/c7md00514h · Cited by 38
D-Ribose Induces Podocyte NLRP3 Inflammasome Activation and Glomerular Injury via AGEs/RAGE Pathway
Hong, J., Li, G., Zhang, Q., Ritter, J. K., Li, W., & Li, P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00259 · Cited by 38
Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
Song, Y., Zhong, C., & Wu, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7051845 · Cited by 37
Chen, D., Chen, Y., Lin, C., Hsieh, C., Wu, Y.-C., Hung, W., Chen, H., & Lan, J. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0569-3 · Cited by 36
Kim, Y., Keogh, J. B., Deo, P., & Clifton, P. M. (2020) · Nutrients · doi:10.3390/nu12061767 · Cited by 35
Gupta, A., Tripathi, A. K., Tripathi, R. L., Madhu, S. V., & Banerjee, B. (2007) · PubMed · Cited by 34
RAGE and glyoxalase in kidney disease
Inagi, R. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9689-8 · Cited by 34
Deo, P., Keogh, J. B., Price, N., & Clifton, P. M. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14121553 · Cited by 32
Do, M. H., Hur, J., Choi, J., Kim, Y., Park, H., & Ha, S. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092774 · Cited by 32
Yubero‐Serrano, E. M., García‐Ríos, A., Delgado‐Lista, J., Delgado‐Casado, N., Pérez‐Martínez, P., Rodríguez-Cantalejo, F., Fuentes, F. J., Cruz‐Teno, C., Túnez, I., Tasset-Cuevas, I., et al. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03381.x · Cited by 31
Renal Proximal Tubular Metabolism of Protein-Linked Pentosidine, an Advanced Glycation End Product
Asano, M., Fujita, Y., Ueda, Y., Suzuki, D., Miyata, T., Sakai, H., & Saitō, A. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000065032 · Cited by 31
Vytášek, R., Šedová, L., & Vilím, V. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-83 · Cited by 30
Kim, D. Y., Kang, M., Lee, E., Kim, Y., Oh, H., & Kang, Y. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800302 · Cited by 30
Role of Neuropilin-1 in Diabetic Nephropathy
Bondeva, T., & Wolf, G. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4061293 · Cited by 28
Shen, C., Wu, C.-H., Lu, C., Kuo, Y., Li, K., Hsieh, S., & Yu, C. (2019) · Molecules · doi:10.3390/molecules24132461 · Cited by 27
Self-citationBondeva, T., Wojciech, S., & Wolf, G. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00575.2010 · Cited by 25
Oleniuc, M., Secara, I., Onofriescu, M., Hogas, S. M., Voroneanu, L. E., Siriopol, D. C., & Covic, A. C. (2011) · PubMed · Cited by 24
Bondeva, T., & Wolf, G. (2009) · American Journal of Nephrology · doi:10.1159/000227762 · Cited by 24
Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication
Monnier, V. M., & Taniguchi, N. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9704-0 · Cited by 24
Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats
Waanders, F., Greven, W. L., Baynes, J., Thorpe, S. R., Kramer, A. B., Nagai, R., Sakata, N., van Goor, H., & Navis, G. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh939 · Cited by 23
DNA-aptamers raised against AGEs as a blocker of various aging-related disorders
Yamagishi, S., Taguchi, K., & Fukami, K. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9682-2 · Cited by 23
Resveratrol in the foodomics era: 1:25,000
Khakimov, B., & Engelsen, S. B. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13425 · Cited by 23
Knani, I., Bouzidi, H., Zrour, S., Bergaoui, N., Hammami, M., & Kerkeni, M. (2018) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563217733500 · Cited by 23
Lu, H., Xu, S., Liang, X., Dai, Y.-Y., Huang, Z., Ren, Y., Lin, J., & Liu, X. (2018) · Inflammation · doi:10.1007/s10753-018-0913-5 · Cited by 23
Sánchez, E., Baena‐Fustegueras, J. A., de la Fuente, M. C., Gutiérrez-Carrasquilla, L., Bueno, M., Ros, S., & Lecube, A. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.02.002 · Cited by 21
Son, K. H., Son, M., Ahn, H., Oh, S., Yum, Y., Choi, C. H., Park, K. Y., & Byun, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.056 · Cited by 20
Yuan, G., Si, G., Hou, Q., Li, Z., Xu, K., Wang, Y., Wang, W., Xu, X., Zhang, L., Sun, X., et al. (2020) · BioMed Research International · doi:10.1155/2020/8607418 · Cited by 20
Dadonienė, J., Čypienė, A., Ryliškytė, L., Rugienė, R., Ryliškienė, K., & Laucevičius, A. (2015) · Disease Markers · doi:10.1155/2015/837470 · Cited by 18
Dhar, A., Dhar, I., Bhat, A., & Desai, K. M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.006 · Cited by 18
Wang, B., Sun, Y., Sang, Y., Liu, X., & Liang, J. (2018) · Medicine · doi:10.1097/md.0000000000012633 · Cited by 18
Federico, G., Gori, M., Randazzo, E., & Vierucci, F. (2016) · SAGE Open Medicine · doi:10.1177/2050312116682126 · Cited by 16 · cited 1×
“[92] indirectly confirmed that skin AGE accumulation in breastfed infants from smoking mothers was higher than that from nonsmoking mothers.”
BackgroundXu, S., Zhou, X., Zhu, C.-J., Qin, W. D., Zhu, J., Zhang, K., Li, H.-J., Lü, X., Lian, K., Li, C., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00626 · Cited by 13
Lee, Y. M., Kim, J., Kim, C., Jo, K., Yoo, N. H., Sohn, E., & Kim, J. S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.022 · Cited by 11
Yamashita, H., Fukushima, E., Shimomura, K., Hirose, H., Nakayama, K., Orimo, N., Mao, W., Katsuta, N., Nishimon, S., & Ohnuma, T. (2020) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1824 · Cited by 11
Increased advanced glycation end product specific fluorescence in repeatedly heated used cooking oil
Chhabra, A., Bhatia, A., Ram, A. K., & Goel, S. (2017) · Journal of Food Science and Technology · doi:10.1007/s13197-017-2682-9 · Cited by 9
McRobert, E. A., & Bach, L. A. (2015) · Nephrology · doi:10.1111/nep.12526 · Cited by 6
Cited by
Twarda-Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 746
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
Xiang, G., Guo, S., Xing, N., Du, Q., Qin, J., Gao, H., Zhang, Y., & Wang, S. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500150 · Cited by 18
Metadata
- Authors
- Shen, C.-Y., Lu, C.-H., Wu, C.-H., Li, K.-J., Kuo, Y.-M., Hsieh, S.-C., & Yu, C.-L.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-11-27
- Volume
- 25
- Issue
- 23
- Pages
- 5591
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3106899554
- Cited by
- 301
- References
- 157
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.